Trials / Conditions / Stage IIA Prostate Cancer AJCC v8

Stage IIA Prostate Cancer AJCC v8

18 registered clinical trials studyying Stage IIA Prostate Cancer AJCC v8 — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Acti NCT05852041	Northwestern University	EARLY_Phase 1
Active Not Recruiting	RElugolix VErsus LeUprolide Cardiac Trial NCT05320406	Emory University	Phase 2
Suspended	Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer NCT04981834	University of Southern California	N/A
Active Not Recruiting	Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer NCT04985565	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Pro NCT04519879	City of Hope Medical Center	Phase 2
Terminated	Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation The NCT04927559	University of Southern California	—
Active Not Recruiting	Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Tr NCT04624256	Jonsson Comprehensive Cancer Center	N/A
Terminated	Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer NCT04457245	Jonsson Comprehensive Cancer Center	Phase 3
Completed	An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prost NCT04318028	University of Southern California	N/A
Withdrawn	Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer NCT04399824	Jonsson Comprehensive Cancer Center	N/A
Active Not Recruiting	Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and T NCT04189770	M.D. Anderson Cancer Center	—
Withdrawn	Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate NCT04288336	Mayo Clinic	EARLY_Phase 1
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Active Not Recruiting	Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before NCT03899987	Roswell Park Cancer Institute	Phase 2
Active Not Recruiting	Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans NCT04215029	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treat NCT04253483	Rutgers, The State University of New Jersey	Phase 2
Terminated	Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer NCT03570476	University of Washington	Phase 2
Active Not Recruiting	Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveill NCT03575832	M.D. Anderson Cancer Center	N/A